Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers discover antibodies to block common respiratory viruses that put bone marrow and stem cell transplant patients at risk.
A small group of adults in remission had persisting mutations that predicted their risk of death from having the cancer return.
Monoclonal antibodies used to prevent COVID-19 in immunocompromised people aren’t active against new virus variants.
Responses to the off-the-shelf treatment were observed in 95% of patients.
People who followed a protective diet and those on a standard hospital diet had a similar likelihood of infections.
Research at #ASH22 calls into question longstanding assumptions and charts a path for gentler therapies.
Tests prevented relapse and limited graft-vs.-host disease (GVHD) in laboratory models of leukemia and multiple myeloma.
Grammy Award winner Jon Batiste married author Suleika Jaouad a day before a bone marrow transplant to treat her acute myeloid leukemia.
Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.
Hospitals are filling up with COVID-19 patients and other medical conditions are going untreated.
Rikako Ikee, who competed in the 2016 Olympics at age 16, was diagnosed with leukemia in early 2019, prompting a yearlong hiatus.
Researchers hope to combine gene editing with a less toxic stem cell transplant. Findings may apply to cancer and other illnesses.
Experts say treatment decisions should depend on the individual and factors such as cancer stage.
Cancer treatments can cause long-term problems linked to aging, such as heart problems and brittle bones.
The short answer is yes. but the procedure isn’t suitable for everyone.
Bone marrow transplants can cure many diseases, but more donors are needed.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.